Merlyn Xavier Pulikkathara

Dr. Merlyn Xavier Pulikkathara

Physics, Prairie View A&M University, Prairie View, Texas, USA
orcid
Assistant Professor of Physics at Prairie View A&M Universit...

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2010 in Small
Verified
Journal Article
Closed access
PDF file
RSRita E. Serda
Rita E. Serda
AMAaron Mack
Aaron Mack
MPMerlyn Xavier Pulikkathara
Merlyn Xavier Pulikkathara
AZAna Maria Zaske
Ana Maria Zaske
CCCiro Chiappini
Ciro Chiappini
MFMauro Ferrari
Mauro Ferrari

27 March 2008 in Chemistry of Materials
Verified
Journal Article
Closed access
MPMerlyn Xavier Pulikkathara
Merlyn Xavier Pulikkathara
OKOleksandr V. Kuznetsov
Oleksandr V. Kuznetsov
VKValery N. Khabashesku
Valery N. Khabashesku

10 January 2017 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MHMayra Hernández-Rivera
Mayra Hernández-Rivera
IKIsh Kumar
Ish Kumar
SCStephen Y. Cho
Stephen Y. Cho
BCBenjamin Y. Cheong
Benjamin Y. Cheong
MPMerlyn Xavier Pulikkathara
Merlyn Xavier Pulikkathara
LWLon Wilson
Lon Wilson

12 May 2008 in Nanotechnology
Verified
Journal Article
Closed access
VRVijaya K Rangari
Vijaya K Rangari
MYMohammed Yousuf
Mohammed Yousuf
SJShaik Jeelani
Shaik Jeelani
MPMerlyn Xavier Pulikkathara
Merlyn Xavier Pulikkathara
VKValery N Khabashesku
Valery N Khabashesku
Alignment of pristine carbon nanotubes (P-CNTs) and fluorinated carbon nanotubes (F-CNTs) in nylon-6 polymer composite fibers (PCFs) has been achieved using a single-screw extrusion method. CNTs have been used as filler reinforcements to enhance the mechanical and thermal properties of nylon-6 composite fibers. The composites were fabricated by dry mixing nylon-6 polymer powder with the CNTs as the first step, then followed by the melt extrusion process of fiber materials in a single-screw extruder. The extruded fibers were stretched to their maxima and stabilized using a godet set-up. Finally, fibers were wound on a Wayne filament winder machine and tested for their tensile and thermal properties. The tests have shown a remarkable change in mechanical and thermal properties of nylon-6 polymer fibers with the addition of 0.5 wt% F-CNTs and 1.0 wt% of P-CNTs. To draw a comparison between the improvements achieved, the same process has been repeated with neat nylon-6 polymer. As a result, tensile strength has been increased by 230% for PCFs made with 0.5% F-CNTs and 1% P-CNTs as additives. These fibers have been further characterized by DSC, Raman spectroscopy and SEM which confirm the alignment of CNTs and interfacial bonding to nylon-6 polymer matrix.

1 January 2006 in Mendeleev Communications
Verified
Journal Article
Closed access
VKValery N. Khabashesku
Valery N. Khabashesku
MPMerlyn Xavier Pulikkathara
Merlyn Xavier Pulikkathara

3 February 2019 in OncoImmunology
Verified
Journal Article
Closed access
NDNeeraja Dharmaraj
Neeraja Dharmaraj
SPStacey L. Piotrowski
Stacey L. Piotrowski
CHChen Huang
Chen Huang
JNJared M. Newton
Jared M. Newton
LGLeonard S. Golfman
Leonard S. Golfman
SYSimon Young
Simon Young
Immunotherapeutic treatments in head and neck cancer clinical trials include cancer vaccines targeting foreign viral antigens or mutational neoantigens derived from cancer-expressed proteins. Anti-tumor immune responses place cancer cells under selective pressure to lose or downregulate target antigens; therefore, vaccination against virus- or host- “driver” oncogenes are proposed as a strategy to overcome immune escape. Herein, we demonstrate the impact of immunogenic viral antigens on anti-tumor response and immune editing in MOC2-E6E7, a syngeneic murine oral cancer cell line expressing HPV-16 E6 and E7 oncoproteins. Using orthotopic syngeneic models, we observed in vivo tumor growth kinetics of MOC2-E6E7 is delayed in immunocompetent mice compared to parental MOC2 tumors. In contrast, tumor growth remained similar in Rag1-/- mice lacking adaptive immunity. MOC2-E6E7 tumors demonstrated an “inflamed” or immune-activated tumor microenvironment and greater infiltration of CD8+ T cells compared to MOC2. By real-time PCR, we detected downregulation of E6 and E7 genes in MOC2-E6E7 tumors only in immunocompetent mice, suggesting the loss of ectopic viral antigen expression due to immune editing. We then assessed the efficacy of a biomaterials-based mesoporous silica rod (MSR) cancer vaccine targeting HPV-16 E7 in our model. Vaccination induced robust infiltration of antigen-specific CD8+ T cells, which led to tumor growth delay and modestly prolonged survival in MOC2-E6E7 tumors. Increased efficacy was seen in a separate head and neck cancer tumor model, mEER, which obligately expresses E7 antigen. Collectively, our data highlight the need for both immunogenicity and ‘driver’ status of target antigens to be considered in cancer vaccine design.